A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway

Sae‐Bom Yoon(Chungnam National University), Heeyeong Cho(Korea Research Institute of Chemical Technology)
Acta Pharmaceutica Sinica B
December 5, 2022
Cited by 40


Related Papers

No related papers found

Powered by citation graph analysis